
This study aimed to determine the incidence of head and neck cancer (HNC) in patients presenting with Globus pharyngeus (GP). Over 4 years, only 1% of 377 GP patients developed HNC. This research provides valuable reassurance to otolaryngologists when evaluating patients with GP, indicating a low likelihood of underlying head and neck cancer.
Like
Save
Share